ESMO 2023: Experts Preview Anticipated Data Spanning Tumor T

The 2023 ESMO Congress, which is taking place in Madrid, Spain, and will continue to be accessible online via a virtual platform, is gearing up to kick off, and the oncology community is ready to learn more about the latest data across malignancies.

Related Keywords

Geneva , Genè , Switzerland , Massachusetts , United States , Madrid , Spain , Ibiayi Dagogo Jack , Kishor Ganti , Novartis Pluvicto , Pembrolizumab Keytruda , Heather Mcarthur , Daiichi Sankyo , Balazs Halmos , Genentech Alecensa , Heather Wakelee , Jeffreys Weber , Dagogo Jack , Christopherk Glanz , Perlmutter Cancer Center , Bladder Cancer Research , Melanoma Research Program , Department Of Internal Medicine , Division Of Oncology Hematology , Genentech , Harvard Medical School , Pamela Buffett Cancer Center , Drug Administration , Novartis , Adventhealth Cancer Institute , Breast Cancer Program At Simmons Center , Department Of Oncology , Ut Southwestern Medical Center , Clinical Research Unit , Department Of Medicine , Bristol Myers Squibb , Langone Health , University Of Nebraska Medical Center , Clinical Breast Cancer Research , Clinical Science , Montefiore Einstein Comprehensive Cancer , Massachusetts General , Nebraska Medical Center , Respiratory Committee , Clinical Trials , Small Cell Lung Cancer Committee , National Comprehensive Cancer Network , Genitourinary Oncology , Adventhealth Cancer , Internal Medicine , Breast Cancer Program , Simmons Cancer Center , Komen Distinguished Chair , Updated October , Myers Squibb , Oncology Annual Meeting , Jesmo , Esmo Congress , Onclive , Melanoma , Renal Cell Carcinoma , Prostate Cancer , Breast Cancer , Lung Cancer , Mariposa , Amivantamab Plus Lazertinib , Osimertinib , Tropion Lung01 , Antibody Drug Conjugate , Sadc , Datopotamab Deruxtecan , Checkmate 77t , Pembrolizumab , Nivolumab , Immunotherapy , Keynote 671 , Perioperative Pembrolizumab , Alina , Adjuvant Alectinib ,